| Phase 1 | 4 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1 | ||||
| NCT05304377 | A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia | Chronic Myeloid Leukemia | Recruiting | 2026-04-01 |
| NCT06787144 | ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in… | CML (Chronic Myelogenous Leukemia) | Recruiting | 2025-07-01 |
| NCT06328738 | ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast… | HER2-positive Breast Cancer | Active, Not Recruiting | 2025-11-19 |
| NCT05650879 | ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer | HER2 Mutant Non-small Cell Lung Cancer | Active, Not Recruiting | 2025-07-15 |
Breast Cancer (2) · Chronic Myeloid Leukemia (CML) (2) · HER2-Positive Cancer (2) · Leukemia (2) · Colorectal Cancer (1) · Gastric Cancer (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1)